
ACTINIUM PHARMACEUTICALS INC
ATNMNYSE AMERICAN๐ #3620 by market capEarnings Nov 13US Equity
$0.79โฒ $0.02 (+2.97%)
๐ After hours$0.79โผ 0.39%Regular close ยท extended-hours price shown1hโ
24hโฒ 3.0%
7dโฒ 5.7%
14dโผ 5.5%
30dโผ 15.3%
1yโผ 48.2%
๐ฆMarket Cap
$25M
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
278.0x
Expensive
Otter Score
53
Weak
Earnings
Q3 ยท 2026Reported 2026-08-07Earnings Per Share
Actual
0.89
Expected
0.89
inline
+0.00%
YoY +504.50%
Revenue
Actual
$35.00M
Expected
$35.00M
inline
+0.00%
Consensus estimates
Recent quarters
Q3 2026
0.89
inline
Q2 2026
-0.18
beat
Q1 2026
-0.19
miss
Q4 2025
-0.16
beat